Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II open-label ceritinib study in ROS1-rearranged non-small cell lung cancer
KCT0003066Phase 2Active, not recruiting
- Sponsor
- Asan Medical Center
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ceritinib in non-small cell lung cancer (NSCLC), sponsored by Asan Medical Center. Started Mar 2018; status: active, not recruiting.
02
Drugs
ceritinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on KCT0003066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003066.